257 related articles for article (PubMed ID: 9368408)
1. Chromoblastomycosis--a clinical and mycological study of 71 cases from Sri Lanka.
Attapattu MC
Mycopathologia; 1997; 137(3):145-51. PubMed ID: 9368408
[TBL] [Abstract][Full Text] [Related]
2. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
Park SG; Oh SH; Suh SB; Lee KH; Chung KY
Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
[TBL] [Abstract][Full Text] [Related]
3. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
4. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
Iwatsu T; Miyaji M; Taguchi H; Okamoto S
Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
[TBL] [Abstract][Full Text] [Related]
6. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil).
Silva JP; de Souza W; Rozental S
Mycopathologia; 1998-1999; 143(3):171-5. PubMed ID: 10353215
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chromoblastomycosis with terbinafine: experience with four cases.
Bonifaz A; Saúl A; Paredes-Solis V; Araiza J; Fierro-Arias L
J Dermatolog Treat; 2005 Feb; 16(1):47-51. PubMed ID: 15897168
[TBL] [Abstract][Full Text] [Related]
8. Chromoblastomycosis.
Milam CP; Fenske NA
Dermatol Clin; 1989 Apr; 7(2):219-25. PubMed ID: 2670367
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
11. Chromoblastomycosis associated with Fonsecaea pedrosoi in a carpenter handling exotic woods.
Menezes N; Varela P; Furtado A; Couceiro A; Calheiros I; Rosado L; Mota G; Baptista A
Dermatol Online J; 2008 Feb; 14(2):9. PubMed ID: 18700112
[TBL] [Abstract][Full Text] [Related]
12. Chromoblastomycosis in India.
Sharma NL; Sharma RC; Grover PS; Gupta ML; Sharma AK; Mahajan VK
Int J Dermatol; 1999 Nov; 38(11):846-51. PubMed ID: 10583618
[TBL] [Abstract][Full Text] [Related]
13. Chromoblastomycosis: clinical and mycologic experience of 51 cases.
Bonifaz A; Carrasco-Gerard E; Saúl A
Mycoses; 2001; 44(1-2):1-7. PubMed ID: 11398635
[TBL] [Abstract][Full Text] [Related]
14. Case report: Fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: Disseminated chromoblastomycosis caused by phialophora.
Qiu Y; Zhang J; Tang Y; Zhong X; Deng J
J Infect Chemother; 2019 Dec; 25(12):1031-1036. PubMed ID: 31229375
[TBL] [Abstract][Full Text] [Related]
15. Chromomycosis caused by Philaphora pedrosoi in eastern Nigeria.
Gugnani HC; Egere JU; Suseelan AV; Okoro AN; Onuigbo WI
J Trop Med Hyg; 1978 Oct; 81(10):208-10. PubMed ID: 731762
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Fransisca C; He Y; Chen Z; Liu H; Xi L
Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
[TBL] [Abstract][Full Text] [Related]
19. Secretion of five extracellular enzymes by strains of chromoblastomycosis agents.
Souza TF; Scroferneker ML; Costa JM; Carissimi M; Corbellini VA
Rev Inst Med Trop Sao Paulo; 2008; 50(5):269-72. PubMed ID: 18949343
[TBL] [Abstract][Full Text] [Related]
20. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
